Condition: Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) · Solid Organ Transplant Complications · Lymphoproliferative Disorders · Sponsor: Pierre Fabre Medicament
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) after failure of rituximab (SOT-R) and rituximab plus chemotherapy (SOT-R+C) or (2) allogeneic hematopoietic cell transplant (HCT) after failure of rituximab.
This description comes directly from the study's public registry record.
Anke Friedetzky · (000) 000-0000 · ATA129-EBV-302_medical.team@pierre-fabre.com
Marie Bosredon · 7 84 14 59 82 · marie.bosredon@pierre-fabre.com
Always discuss trial participation with your own doctor first.
| City of Hope (Adults and Pediatrics) | Duarte, California, United States | Completed |
| University of California San Diego Moores Cancer Center (Adults only) | La Jolla, California, United States | Completed |
| Loma Linda University Medical Center (Adults only) | Loma Linda, California, United States | Recruiting |
| Children's Hospital Los Angeles, Div. of Research Immunology/BMT (Adults and Pediatrics) | Los Angeles, California, United States | Recruiting |
| UCLA Medical Center (Adults and Pediatrics) | Los Angeles, California, United States | Completed |
| University of California Davis Comprehensive Cancer Center (Adults only) | Sacramento, California, United States | Completed |
| Yale University (Adults and Pediatrics) | New Haven, Connecticut, United States | Completed |
| MedStar Georgetown University Hospital (Adults and Pediatrics) | Washington D.C., District of Columbia, United States | Recruiting |
| University of Florida (Adults and Pediatrics) | Gainesville, Florida, United States | Completed |
| University of Miami/Jackson Memorial Hospital (Adults only) | Miami, Florida, United States | Recruiting |
| Winship Cancer Institute (Adults only) | Atlanta, Georgia, United States | Completed |
| Arthur M. Blank Hospital (Pediatrics) | Atlanta, Georgia, United States | Recruiting |
+ 59 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03394365